Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 111451-111500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03050931
Electrical Impedance Tomography of Epilepsy
N/A
Active, not recruiting
42 participants
Started: May 30, 2017 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT03153475
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population
NA
Active, not recruiting
400 participants
Started: May 30, 2017 · Completed: Mar 31, 2029
1 condition
1 sponsor
38 locations
NCT03132311
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
PHASE4
Recruiting
400 participants
Started: May 29, 2017 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02926690
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
PHASE1
Active, not recruiting
70 participants
Started: May 29, 2017 · Completed: Sep 30, 2027
1 condition
1 sponsor
5 locations
NCT03117946
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
NA
Recruiting
220 participants
Started: May 29, 2017 · Completed: Nov 29, 2026
2 conditions
1 sponsor
4 locations
NCT03113500
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
PHASE2
Active, not recruiting
48 participants
Started: May 25, 2017 · Completed: Aug 12, 2025
11 conditions
2 sponsors
5 locations
NCT03067181
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
PHASE3
Recruiting
1,780 participants
Started: May 25, 2017 · Completed: Jun 30, 2027
30 conditions
2 sponsors
629 locations
NCT02955082
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
PHASE2
Active, not recruiting
305 participants
Started: May 25, 2017 · Completed: Sep 30, 2025
1 condition
13 sponsors
1 location
NCT03065335
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
PHASE1
Recruiting
150 participants
Started: May 25, 2017 · Completed: Jan 1, 2028
3 conditions
1 sponsor
1 location
NCT05390983
Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis
NA
Recruiting
40 participants
Started: May 25, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT02838316
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
PHASE1
Active, not recruiting
18 participants
Started: May 24, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02862275
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
PHASE1
Active, not recruiting
40 participants
Started: May 24, 2017 · Completed: Nov 21, 2026
3 conditions
1 sponsor
9 locations
NCT03161652
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
PHASE2
Recruiting
120 participants
Started: May 24, 2017 · Completed: Jun 30, 2026
2 conditions
6 sponsors
2 locations
NCT03118492
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
PHASE1
Active, not recruiting
22 participants
Started: May 24, 2017 · Completed: May 26, 2026
1 condition
2 sponsors
1 location
NCT05361603
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
N/A
Recruiting
1,500 participants
Started: May 24, 2017 · Completed: Feb 14, 2030
5 conditions
1 sponsor
1 location
NCT02878434
Fertility Preservation in Young Women With Cancer
N/A
Recruiting
2,000 participants
Started: May 23, 2017 · Completed: Jul 31, 2032
2 conditions
7 sponsors
2 locations
NCT03160794
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NA
Recruiting
100 participants
Started: May 23, 2017 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT03054519
Improve PAD PERformance With METformin
PHASE3
Active, not recruiting
203 participants
Started: May 23, 2017 · Completed: Nov 30, 2025
1 condition
1 sponsor
5 locations
NCT03745560
Intraoperative EABR for Decision Making
N/A
Recruiting
15 participants
Started: May 23, 2017 · Completed: May 23, 2026
2 conditions
1 sponsor
1 location
NCT03138720
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
PHASE2
Active, not recruiting
24 participants
Started: May 23, 2017 · Completed: Aug 1, 2025
4 conditions
1 sponsor
1 location
NCT03068663
Microbiota and the Lung Cancer
NA
Recruiting
40 participants
Started: May 23, 2017 · Completed: Oct 30, 2029
1 condition
4 sponsors
1 location
NCT03107520
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
EARLY_PHASE1
Recruiting
125 participants
Started: May 22, 2017 · Completed: Apr 30, 2030
1 condition
3 sponsors
1 location
NCT02989025
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
PHASE2
Recruiting
60 participants
Started: May 22, 2017 · Completed: Jan 31, 2027
2 conditions
1 sponsor
1 location
NCT02589522
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors
PHASE1
Active, not recruiting
15 participants
Started: May 22, 2017 · Completed: Sep 18, 2026
7 conditions
1 sponsor
9 locations
NCT03036007
Physiotherapy After Anterior Cervical Spine Surgery
NA
Active, not recruiting
20 participants
Started: May 22, 2017 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT03229200
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
PHASE4
Enrolling by invitation
600 participants
Started: May 22, 2017 · Completed: May 10, 2027
5 conditions
2 sponsors
98 locations
NCT03085212
Strategies for Pregnancy Achievement
NA
Active, not recruiting
40 participants
Started: May 21, 2017 · Completed: Dec 31, 2026
4 conditions
3 sponsors
1 location
NCT03133923
Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
PHASE2
Active, not recruiting
1,080 participants
Started: May 20, 2017 · Completed: Jul 1, 2024
1 condition
2 sponsors
1 location
NCT03146650
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
PHASE2
Active, not recruiting
25 participants
Started: May 19, 2017 · Completed: Aug 11, 2025
7 conditions
3 sponsors
1 location
NCT03128866
Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery
EARLY_PHASE1
Recruiting
80 participants
Started: May 19, 2017 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT03491176
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
N/A
Active, not recruiting
100 participants
Started: May 18, 2017 · Completed: Oct 31, 2025
3 conditions
2 sponsors
1 location
NCT02997020
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)
N/A
Active, not recruiting
30 participants
Started: May 18, 2017 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
PHASE2
Active, not recruiting
109 participants
Started: May 18, 2017 · Completed: Jun 27, 2026
44 conditions
1 sponsor
142 locations
NCT03548792
Comparison of an Old Versus a New Total Knee Replacement
NA
Active, not recruiting
185 participants
Started: May 18, 2017 · Completed: Jul 5, 2029
1 condition
1 sponsor
1 location
NCT03164174
Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels
N/A
Active, not recruiting
64 participants
Started: May 17, 2017 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03313271
China Lymphoma Patient Registry Study
N/A
Recruiting
5,000 participants
Started: May 17, 2017 · Completed: Aug 30, 2027
1 condition
6 sponsors
1 location
NCT03179774
Endovascular Revascularization for Chronic Carotid Artery Occlusion Trial
NA
Recruiting
200 participants
Started: May 17, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03741920
Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status
NA
Active, not recruiting
231 participants
Started: May 17, 2017 · Completed: Oct 31, 2025
1 condition
1 sponsor
12 locations
NCT03152058
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
PHASE2
Recruiting
55 participants
Started: May 17, 2017 · Completed: Dec 31, 2026
4 conditions
4 sponsors
3 locations
NCT03209414
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
N/A
Recruiting
1,000 participants
Started: May 17, 2017 · Completed: Dec 31, 2027
5 conditions
1 sponsor
1 location
NCT03148743
FMT in Gut aGVHD Treated
N/A
Recruiting
50 participants
Started: May 16, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03122197
Study of Letrozole in Recurrent Gliomas
EARLY_PHASE1
Recruiting
39 participants
Started: May 16, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03225417
Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
PHASE1/PHASE2
Active, not recruiting
142 participants
Started: May 16, 2017 · Completed: Dec 31, 2024
2 conditions
2 sponsors
8 locations
NCT03639701
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: May 16, 2017 · Completed: May 31, 2026
2 conditions
9 sponsors
1 location
NCT03409159
Austrian Left Atrial Appendage Closure Registry
N/A
Recruiting
200 participants
Started: May 16, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT02845323
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
PHASE2
Active, not recruiting
15 participants
Started: May 16, 2017 · Completed: Dec 31, 2026
2 conditions
2 sponsors
5 locations
NCT02627443
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1
Active, not recruiting
35 participants
Started: May 16, 2017 · Completed: Jun 3, 2026
12 conditions
1 sponsor
14 locations
NCT03145181
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
302 participants
Started: May 16, 2017 · Completed: May 28, 2027
1 condition
1 sponsor
13 locations
NCT05253560
Prodromal Parkinsonian Features in GBA1 Mutation Carriers
N/A
Recruiting
600 participants
Started: May 16, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03436238
Myocardial Injury in Noncardiac Surgery in Sweden
N/A
Active, not recruiting
1,269 participants
Started: May 15, 2017 · Completed: Dec 31, 2025
2 conditions
3 sponsors
7 locations
Previous
1
More pages
2227
2228
2229
2230
2231
2232
2233
More pages
2369
Next